摘要
治疗性血管再生被认为是治疗缺血性疾病最具潜力的策略。成熟血管的重建,是功能性血管再生的关键,是一个涉及多种血管生成因子的复杂过程。已试图通过传递载体或其他可调节血管生成的大分子来促进功能性血管再生。然而,这些治疗性血管生成因子大多局限于直接肌肉注射。本研究表明,相比于肌肉注射,流变肢体静脉 (HLV)注射靶向PHD2 (shPHD2) 的裸体短发夹RNA表达质粒于严重后肢缺血小鼠,不仅能够增加HIF-依赖型和HIF-非依赖型血管生长因子的表达,而且还能增加更有效地参与多种内源性通路的组织保护因子的表达。我们还发现随着这些因子的表达水平仅因缺血条件而稍微上调,PHD2-沉默增强了先天内生恢复机制。最后,研究表明shPHD2的HLV注射促进了成熟功能性血管的形成,并且最终更有效地增强了缺血后肢的恢复。这些结果表明shPHD2的HLV传递可能成为一种有前途的治疗策略,通过增强先天内源性通路来促进严重肢体缺血疾病的血管再生。
关键词: 严重肢体缺血,基因沉默,流变肢体静脉传递,PHD2,血管再生。
Current Gene Therapy
Title:Prolyl Hydroxylase Domain-2 Silencing Induced by Hydrodynamic Limb Vein Injection Enhances Vascular Regeneration in Critical Limb Ischemia Mice through Activation of Multiple Genes
Volume: 15 Issue: 3
Author(s): Shourong Wu, Jing Zhang, Can Huang, Huizhen Jia, Yunxia Wang, Zhiling Xu, Li Yang, Makoto Miyagishi and Vivi Kasim
Affiliation:
关键词: 严重肢体缺血,基因沉默,流变肢体静脉传递,PHD2,血管再生。
摘要: Therapeutic revascularization had been considered as the most potential strategy for treating ischemic diseases. Reconstruction of mature blood vessels, which is the key for functional revascularization, is a complex process involving multiple angiogenesis factors. Attempts had been made to promote functional revascularization by delivering vectors or other macromolecules that could positively regulate angiogenesis; however, the delivery method of these therapeutic angiogenesis factors had been mostly limited to direct intramuscular injection. In this study, we showed that compared to intramuscular injection, the hydrodynamic limb vein (HLV) injection of naked shorthairpin RNA expression plasmid targeting PHD2 (shPHD2) into critical himblimb ischemia mice could increase not only the expressions of HIF-dependent and HIF-independent angiogenic factors, but also tissue protective factors involved in various endogenous pathways more efficiently. We also found that PHD2-silencing enhanced innate endogenous recovery mechanism, as the expression levels of these factors had been slightly upregulated merely by the ischemic condition. Finally, we showed that HLV injection of shPHD2 promoted the formation of mature and functional vessels, and thus, enhances the recovery of ischemic hindlimbs more efficiently. These results suggest that HLV delivery of shPHD2 might become a promising treatment strategy to promote vascular regeneration in critical limb ischemia disease via enhancing innate endogenous pathways.
Export Options
About this article
Cite this article as:
Shourong Wu, Jing Zhang, Can Huang, Huizhen Jia, Yunxia Wang, Zhiling Xu, Li Yang, Makoto Miyagishi and Vivi Kasim , Prolyl Hydroxylase Domain-2 Silencing Induced by Hydrodynamic Limb Vein Injection Enhances Vascular Regeneration in Critical Limb Ischemia Mice through Activation of Multiple Genes, Current Gene Therapy 2015; 15 (3) . https://dx.doi.org/10.2174/156652321503150329003735
DOI https://dx.doi.org/10.2174/156652321503150329003735 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Improving Red Blood Cell K-Uptake and its Impact on O2/CO2 Exchange, and NO-Generation in Microvascular CHD: A Novel Therapeutic Approach
Recent Patents on Cardiovascular Drug Discovery Oxidative Stress in the Cochlea: An Update
Current Medicinal Chemistry Apolipoprotein(a) Antisense Oligonucleotides: A New Treatment Option for Lowering Elevated Lipoprotein(a)?
Current Pharmaceutical Design Sex Differences in Biomarkers for Predicting Cardiovascular and Coronary Events
Current Vascular Pharmacology Different Patterns of Statin Use in Patients with Acute Myocardial Infarction
Current Vascular Pharmacology 25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome—Unaltered in Young and not Correlated to Carotid IMT in All Ages
Current Pharmaceutical Design Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
Current Rheumatology Reviews Overview
Mini-Reviews in Medicinal Chemistry The Pharmacogenomics of Anti-Platelet Intervention (PAPI) Study: Variation in Platelet Response to Clopidogrel and Aspirin
Current Vascular Pharmacology Therapeutic Angiogenesis in Ischemic Tissues by Growth Factors and Bone Marrow Mononuclear Cells Administration: Biological Foundation and Clinical Prospects
Current Stem Cell Research & Therapy Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member
Current Clinical Pharmacology Patent Ductus Arteriosus in Extreme Prematurity: Role of Echocar-diography and Other Imaging Techniques
Current Pediatric Reviews Hybrid Stress Testing by Adenosine Infusion and Exercise Myocardial Perfusion Imaging: A Critical Appraisal
Current Cardiology Reviews Nuclear Imaging of Post-infarction Inflammation in Ischemic Cardiac Diseases - New Radiotracers for Potential Clinical Applications
Current Radiopharmaceuticals The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology Molecular Targets of Diabetic Cardiovascular Complications
Current Drug Targets Prediction of Degeneration of Native and Bioprosthetic Aortic Valves:Issue-Related Particularities of Diabetes Mellitus
Infectious Disorders - Drug Targets Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
Current Alzheimer Research The C242T CYBA Polymorphism as a Major Determinant of NADPH Oxidase Activity in Patients with Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry